Martin Abrahamson is an Endocrinology/Metabolic physician affiliated with Joslin Diabetes Center. OpenAlex indexes 83 publications with 5,282 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Joslin Clinic
One Joslin Place
Boston, MA 02215
Telephone
617-732-2501Registry record last updated 8 Jul 2007.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Corcept TherapeuticsProgram year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- Sequel Med Tech, LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
90.6%GLP-1 receptor agonist34%Ozempic51%Trulicity30%Mounjaro12%Rybelsus7%Part D<11 patientsInsulin Analog25.4%Tresiba Flextouch U-10024%Lantus Solostar19%Humalog Kwikpen U-10014%Novolog Flexpen9%Basaglar Kwikpen U-1008%Fiasp Flextouch6%Humalog4%Tresiba Flextouch U-2004%Insulin Lispro Kwikpen U-1003%Xultophy 100-3.63%Admelog Solostar3%Lyumjev2%Toujeo Solostar2%Part D<11 patients+ 4 more classes in this area
Cardiovascular
5.2%Statin2.6%Atorvastatin Calcium62%Rosuvastatin Calcium38%Part D<11 patientsCholesterol absorption inhibitor1.6%Ezetimibe100%Part D<11 patients+ 1 more class in this area
Hormonal (systemic)
3.6%l-Thyroxine3.6%Levothyroxine Sodium100%Part D≥23 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1995–1997 per NIH RePORTER. The latest:
- INSULIN SECRETION AND SENSITIVITY IN GESTATIONAL DIABETES MELLITUS
Beth Israel Deaconess Medical Center
FY1997M01RR001032
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Sylvia Rosas, MD
Joslin Diabetes Center
Jason Gaglia, MD
Joslin Diabetes Center
Lloyd Aiello, MD, PhD
Joslin Diabetes Center
Mary Horlick
Joslin Diabetes Center
Jens J. Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Daniel J. Drucker
University of Toronto
Kenneth Cusi, MD
University of Florida College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”